A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations
Authors:
- 10 July 2021
- journal article
- research article
- Published by Springer Nature in Diabetology International
- Vol. 13 (1) , 177-187
Abstract
Aim Zinc, an essential trace element, has various functions in humans. Zinc deficiency is associated with the elderly, patients with diabetes, and patients with frailty, a common geriatric syndrome. As few studies have reported the effects of anti-diabetic medication on zinc levels, we examined serum zinc concentrations in patients with diabetes and their correlation with anti-diabetic medications, especially in the elderly and patients with frailty, in Japan. Methods This cross-sectional study was conducted in 2014 and included 1033 patients with diabetes. Blood samples were taken, and a survey for the 8-item Short Form Health Survey of the Medical Outcomes Study was conducted. Results Because of renal dysfunction (with an estimated glomerular filtration rate of < 60 mL/min/1.73 m2), 337 patients out of 1033 were excluded. Hypozincemia was observed in 43.8% of the patients with diabetes. In 177 elderly patients with a low physical component summary score, multivariable logistic regression analysis revealed two anti-diabetic medications associated with hypozincemia: GLP-1RA (multivariable-adjusted odds ratio [OR] 0.08, 95% confidence interval [CI] 0.010–0.657, p = 0.019) and metformin (OR 0.415, 95% CI 0.222–0.774, p = 0.006). In addition, metformin had a dose-dependent correlation with zinc levels (R = 0.3067, p < 0.0001). Conclusions Oral administration of metformin in the elderly with diabetes and non-progressive renal dysfunction was not associated with hypozincemia, even at high doses.Keywords
Funding Information
- Research Project on Development of Agricultural Products and Foods with Health-Promoting Benefits (NARO), Japan (A-5)
This publication has 28 references indexed in Scilit:
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- A Molecular Mechanism for Modulating Plasma Zn Speciation by Fatty AcidsJournal of the American Chemical Society, 2012
- Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2011
- Validation testing of a three-component model of Short Form-36 scoresJournal of Clinical Epidemiology, 2011
- Zinc and diabetes — clinical links and molecular mechanismsThe Journal of Nutritional Biochemistry, 2009
- Assessing Items on the SF-8 Japanese Version for Health-Related Quality of Life: A Psychometric Analysis Based on the Nominal Categories Model of Item Response TheoryValue in Health, 2009
- Correlation between zinc status and immune function in the elderlyBiogerontology, 2006
- Zinc: health effects and research priorities for the 1990s.Environmental Health Perspectives, 1994
- Copper, Zinc, Manganese, and Magnesium Status and Complications of Diabetes MellitusDiabetes Care, 1991
- Abnormal zinc metabolism in type II diabetes mellitusThe American Journal of Medicine, 1983